EyeCosTech is pioneering
eye color change & melanin
disorders by laser & bio-tech

The potencial market is 10% globally.

EyeCosTech is pioneering
eye color change & melanin
disorders by laser & bio-tech

The potencial market is 10% globally.

research and development

laser & optics tech

EyeCosTech has been working for 12 years on the development of all the technical equipment necessary for eye color change: The Apolaser Tyron, the IRÎZ scanner and the Analyzer plus software, the Digital Flaremeter, the IRÎZ Photographic Robot and the AI ​​software and the Eye Selfie, Predictor and Simulator 3D smartphone applications.

research and development

bio tech

The biotechnology division of EyeCos Tech has developed innovative solutions for changing eye color using techniques with chemical and immunological substances, with different forms of administration: as eye drops for daily use, application in a single ocular dose, in skin cream and vaccines and gamma globulin for Vitiligo disease.

company

our team

The EyeCos Tech team shines for the professionalism and experience. The founder & CEO is an eye doctor, surgeon and inventor. The CFO has extensive experience in business and financial analysis. The COO has been consultant and manager of ophthalmology companies. The CSA is a Professor on Laser Physics at the Catalonia University (UPC). The Commercial Director is an experienced engineer with great skills in team building and instruction. And the Invest and Legal Affairs Head is a business lawyer, and masters 5 languages perfectly.

goals

usual outcome since 2012

The spectacular cosmetic results of the EyeCos Tech laser are always natural, and vary from sky blue, to turquoise, navy blue, bluish gray, greenish gray and silver gray. The final result depends on the patient’s genetic and immunological characteristics, as well as external factors such as diet, sun exposure and general health. EyeCos Tech always guarantees a very high level of effectiveness, safety and predictability.

Markets

Global Markets

The Market is 10% Globally

newsroom

Press Releases, News
Scientific Publications

contact

Contact for Invest

Markets

Global Markets
The market is 10% globally

newsroom

Press Releases, News
Scientific Publications

contact

Contact for Invest

EyecosTech
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.